The association standards on guidelines for the cognitive clinical diagnosis and treatment of coronary artery disease complicated with depression and anxiety.
10.3760/cma.j.cn112138-20250214-00083
- Collective Name:Psychocardiology Medicine Branch of Chinese Medical Association Beijing Branch;Psychocardiology Education Professional Committee of China Medical Education Association
- Publication Type:Journal Article
- MeSH:
Humans;
Depression/diagnosis*;
Coronary Artery Disease/psychology*;
Anxiety/diagnosis*;
Practice Guidelines as Topic
- From:
Chinese Journal of Internal Medicine
2025;64(9):825-830
- CountryChina
- Language:Chinese
-
Abstract:
Coronary artery disease (CAD), one of the most common cardiovascular diseases (CVD), poses a serious threat to physical and mental health, resulting in a severe disease burden. Psychocardiology medicine focuses on the vital role of psychological factors in the development, diagnosis, and treatment of CVD. The prevalence of depression and anxiety is high in patients with CAD. Furthermore, there is a vital interplay among depression, anxiety, mental stress-induced myocardial ischemia, cognitive impairment, and delirium. Both cognitive impairment and delirium adversely impact the prognosis of patients with CAD, warranting increasing attention and the development of interventions. To further direct the clinic diagnosis and treatment of cognitive impairment in patients with CAD complicated with depression and anxiety, and to thus improve the prognosis of such patients, the Psychocardiology Medicine Branch of Chinese Medical Association Beijing Branch, and Psychocardiology Education Professional Committee of China Medical Education Association, together with over 40 other organizations, including more than 50 experts from several related fields, have developed the association standards on guidelines for the cognitive clinical diagnosis and treatment of CAD complicated with depression and anxiety under the framework of the China standard association (No.T/CAS 812-2024).
